CEACAM5 and cancer: In this context, early screening and accurate diagnosis are of key importance to improve clinical prognosis, and CEA is both a serologic indicator for adjuvant to diagnosis of various cancers and a prognostic biomarker for dynamic monitoring of disease regression (2, 3).